Skip to content

Transverse coloplasty pouch versus end-to-end colo-anal anastomosis as neorectum after laparoscopic intersphincteric resection for ultralow rectal cancer: A prospective control study

Transverse coloplasty pouch versus end-to-end colo-anal anastomosis as neorectum after laparoscopic intersphincteric resection for ultralow rectal cancer: A prospective control study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058476
Enrollment
Unknown
Registered
2022-04-09
Start date
2022-04-01
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ultralow rectal cancer

Interventions

Experimental group:transverse coloplasty pouch
Control group:end-to-end colo-anal anastomosis

Sponsors

Department of Colorectal Surgery, the Characteristic Medical Center of PLA Rocket Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-80 years with low and ultra-low rectal cancer who are eligible for surgery; 2. Patients whose lower extremity of the tumor was less than 2cm from the anorectal ring or less than 5 cm from the anal margin could not undergo pre-resection of rectal cancer to preserve the anus; 3. Rullier classification of low rectal cancer: Type II and Type III.

Exclusion criteria

Exclusion criteria: 1. Preoperative evaluation indicated that the tumor invaded the external anal sphincter, puborectalis, and stage T4 (yT4). 2. Patients who were expected to have positive periannular margins after preoperative evaluation (including those who were still positive after neoadjuvant chemoradiotherapy); 3. There was significant anal incontinence before surgery, with Wexner incontinence score > 10; 4. Patients with anal sphincter injury and anal malformation before operation; 5. Preoperative evaluation of patients who could not tolerate surgery; 6. Those who refuse to be included.

Design outcomes

Primary

MeasureTime frame
clinical efficacy;Physiological indexes and defecation control function;Quality of life and satisfaction;

Secondary

MeasureTime frame
Factors affecting clinical efficacy;Morphological evaluation of colonic pouch;

Countries

China

Contacts

Public ContactDing Jianhua

Department of Colorectal Surgery, the Characteristic Medical Center of PLA Rocket Force

jianhuading75@163.com+86 18910883440

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026